Solvay S.A.: Solvay third quarter 2026 results
Solvay reported Q3 2026 net sales of €1.03B, down 3.3% YoY, and EBITDA of €173M, down 26.6% YoY, impacted by Middle East conflict. The company announced a long-term supply agreement with Viridis for rare earths and continues discussions with OneIM. The Board approved a €0.97 interim dividend. Solvay revised its 2026 EBITDA guidance to €720M-€740M and free cash flow to €120M-€150M.
How this was made
The 30-second read
Why it matters
The earnings miss and lowered guidance are likely to trigger a sell-off, but strategic rare earths initiatives may offer upside.
Market read
First disclosure of Solvay's Q3 2026 results and updated guidance, material for investors in European industrial stocks.
What to watch
Potential recovery from the Jubail plant shutdown and long-term rare earths growth may mitigate downside.
Background
Solvay, a European chemical leader, reported Q3 2026 results impacted by Middle East conflict and soda ash weakness.
Market effects
European chemicals sector may see broader pressure from Middle East conflict exposure.
European markets could dip on earnings disappointment from a major chemical player.
Limited, confined to chemicals and related industrial investors.
Counterpoint
Dividend stability and rare earths supply agreement could support the stock despite short-term earnings miss.
Key entities
- CompanySolvay
European chemicals and materials group listed on Euronext.
- PartnerViridis
Supplier of rare earth feedstock entering a long-term agreement with Solvay.
